Inventiva S.A. (IVA)
Inventiva S.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Inventiva S.A. (IVA) is a Biotechnology company based in FR with a market capitalization of $259.9M. Revenue declined 51.3% year-over-year and free cash flow was negative at -$115.8M. This page tracks IVA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
FR · 114 employees · IPO Jul 10, 2020
Valuation
Valuation & price
$5.13as of May 26, 2026· -28.3% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$259.9M
Market cap
-51.3%
Revenue growth (YoY)
33.7%
Gross margin
-$115.8M
Free cash flow (USD)
-$39.9M
Net debt
Net cash position
259.4%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 6-K filed Jun 12, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Annual reportJun 12, 2026Filing
Annual Report Filed
- 6-K filingJun 12, 2026Filing
Amendment Agreement
- 6-K filingJun 9, 2026Filing
Combined General Meeting Notice
- 6-K filingJun 3, 2026Filing
Subscription Agreement
- Annual reportJun 3, 2026Filing
Annual Report Filed
- Quarterly reportMay 26, 2026Filing
Quarterly Report Filed
- Annual reportMay 22, 2026Filing
Annual Report Filed
- 6-K filingApr 22, 2026Filing
Leadership Team Strengthened
- Annual reportApr 8, 2026Filing
20-F Filed
Questions
Frequently asked questions
What is Inventiva S.A.'s market cap?
Inventiva S.A. (IVA) has a market capitalization of $259.9M.
What is IVA's P/E ratio?
A meaningful P/E ratio is not available for IVA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
Are insiders buying IVA stock?
SEC Form 4 filings show no open-market insider buys at Inventiva S.A. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.